RxDoctor Payments Data

Michael Leonardi

Pediatrics · Charleston, SCNPI 1932295425

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $875 of the $986 with a category attached, or 88.7%. GSK accounts for 88.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $889 and has fallen 94.0% since, to $53 in 2024.

$986in general payments, 2019–2025

Across 7 payments — averaging $140.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$875
  • Neuraxis, Inc.$53
  • Ironshore Pharmaceuticals Inc.$25
  • Sobi, Inc$18
  • Sanofi Pasteur Inc.$11
  • Pfizer$4
$2,038,962in research payments, 2019–2025

Across 502 payments — averaging $4061.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.2M
  • Merck$237K
  • Pfizer$197K
  • GSK$167K
  • AstraZeneca$107K
  • Sanofi Pasteur Inc.$84K
  • plus $39K from 2 others

What the payments were for

  • Consulting fees$87589%
  • Food & beverage$11111%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK1$875
Neuraxis, Inc.1$53
Ironshore Pharmaceuticals Inc.2$25
Sobi, Inc1$18
Sanofi Pasteur Inc.1$11
Pfizer1$4

How this compares

$986 in reported general payments places this provider in the 75th percentile of 969 pediatrics providers in South Carolina.

See all pediatrics providers in South Carolina

Other pediatrics in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →